The growth of this market is mainly driven by the growing number of hospitals across major markets, increasing awareness about complication related to oncoogy treatment coupled with the increasing adoption of treatment planning systems. Moreover, rising R&D investments by the key players operating in the market to develop advanced oncology information systems coupled with growing funding & grants for commercialization and development of oncology information systems are other important factors to drive the market growth in the near future.
The radiotherapy treatment planing system subsegment of treatment planning systems products to hold major market share by 2025
Based on the product, the oncology information systems market is segmented software, and professional services. The software products segment is further divided into patient information systems, treatment planning systems,and treatment management systems & medical image analysis systems. Among the treatment planning system
German health group Siemens Healthineers is set to win EU antitrust approval for its $16.4-billion purchase of U.S. peer Varian Medical Systems Inc in a deal that will make it a world leader in. | February 18, 2021
EU antitrust regulators are set to grant conditional clearance to German health group Siemens Healthineers' $16.4-billion bid for U.S. peer Varian Medical Systems Inc, three people familiar with the matter said.
Global Medical Robots Market 7
The Global Medical Robots Market is set to witness a very successful period with technological advancements occurring frequently, market will rise from its initial estimated value of USD 5.9 billion in 2018 to an estimated value of USD 28.9 billion by 2026 registering a CAGR of 21.8% in the forecast period of 2019-2026
Market Definition: Global Medical Robots Market
Medical Robots are mechanical robots that are used in medical services. They aid in surgeries, rehabilitation or even in dispensing of medical pharmaceutics. Medical robots are used in a variety of surgical practices. These robots act as a tele manipulator acting on behalf of the surgeon to perform hazardous tasks or even the most precise procedures.
The technological advancements such as the introduction of mobile IORT system, rising incidence of cancer, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global intraoperative radiation therapy products market. Additionally, growing clinical trials exploring the use of IORT for various cancer applications is expected to offer lucrative growth opportunities to market players.
The Electron IORT segment to account for the largest share of the intraoperative radiation therapy market, by technology, in 2019
Based on technology, the intraoperative radiation therapy market is segmented into electron IORT and intraoperative brachytherapy. The electron IORT segment is expected to account for the largest share of the market in 2019. IOERT is a suitable option for patients with locally advanced or recurrent cancer such as partial breast and rectal cancer. Thus, rising target patient population, promising clinical trials, and gro